Exelixis Inc. buy Wells Fargo & Company
Start price
30.10.24
/
50%
€29.87
Target price
30.10.25
€33.15
Performance (%)
10.91%
End price
31.10.25
€33.13
Summary
This prediction ended on 31.10.25 with a price of €33.13. The BUY prediction by Wells_Fargo___Compan finished with a performance of 10.91%. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | 0.450% | 0.450% | 4.624% |
| iShares Core DAX® | -1.338% | -5.619% | 3.378% |
| iShares Nasdaq 100 | -1.067% | 2.598% | 19.132% |
| iShares Nikkei 225® | -1.991% | -6.512% | 27.854% |
| iShares S&P 500 | -1.316% | 0.905% | 14.189% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its price target raised by analysts at Wells Fargo & Company from $32.00 to $36.00. They now have an "overweight" rating on the stock.
Ratings data for EXEL provided by MarketBeat
In the thread Trading Exelixis Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten